Close
ACHEMA MIDDLE EAST 2026

EMA Advises Recall of AbbVie, Biogen MS Drug

The European Medicines Agency (EMA) announced the recommended immediate suspension and recall of AbbVie and Biogen’s multiple sclerosis (MS) drug Zinbryta (daclizumab beta) following...

Novartis’ take on what to expect as tech transforms healthcare

He is a medical doctor by training but it is big data and its implications that is engaging his attention and with good reason....

Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology,...

Merck and Eisai collaborate to develop and sell Eisai cancer drug

Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima,...

Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress

Shire plc announced new Phase 3 results from the HELP Study™, a global, multi-center, randomized, double-blind placebo-controlled parallel group trial that evaluated the efficacy...

FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Allergan plc , a leading global pharmaceutical company, announced that the U.S. FDA has approved Allergan's supplemental New Drug Application (sNDA) to expand the...

Sanofi, DNDi Seek EMA Review For Sleeping Sickness Drug

The Paris, France-based drugmaker said it is hoped that the treatment will contribute to the elimination of the disease. The European Medicines Agency has accepted...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...